Hoth Therapeutics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $59 |
Gross Profit | 29 | ||
EBITDA | -1,645 | -2,054 | -1,697 |
EBIT | -3,291 | -4,108 | -3,395 |
Net Income | -1,632 | -2,040 | -1,702 |
Net Change In Cash | 0 | 0 | 59 |
Free Cash Flow | -1,591 | -1,723 | -3,071 |
Cash | 9,654 | 7,562 | 9,292 |
Basic Shares | 6,876 | 4,398 | 4,348 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -66 | -46,871 | -25 | |
EBITDA | -153 | -10,678 | -14,313 | -7,300 |
EBIT | -7,845 | -21,744 | -14,101 | -7,301 |
Net Income | -7,845 | -11,677 | -14,313 | -7,197 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | 738 | |||
Free Cash Flow | -8,447 | -9,371 | -12,207 | -6,300 |
Cash | 9,292 | 6,428 | 8,538 | 2,629 |
Basic Shares | 3,409 | 1,197 | 893 | 494 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.31 |
2024-06-30 | -$0.24 |
2024-03-31 | -$0.46 |
2023-12-31 | -$0.32 |
